Corinna Weber-Schoendorfer
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Communicating medication risks in pregnancy: Towards shared decision making.
Journal: Frontiers in drug safety and regulation
Published: September 24, 2025
Does extended follow-up period after birth improve precision of diagnosis of congenital anomalies? An observational study based on the Berlin Embryotox project.
Journal: European journal of pediatrics
Published: April 10, 2025
When pregnancy termination fails: A tale of two teratogens: methotrexate and misoprostol - A narrative mini-review.
Journal: Seminars in perinatology
Published: December 04, 2024
Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder.
Journal: Obstetrics and gynecology
Published: August 30, 2024
Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated.
Journal: Birth defects research
Published: May 21, 2024
Drifting Too Far From Shore: Paternal Valproate Statement by the European Medicines Agency (EMA).
Journal: Pharmacoepidemiology and drug safety
Published: February 13, 2024
Methotrexate in pregnancy: still many unanswered questions.
Journal: RMD open
Published: January 09, 2023
The risk of questioning the safety of drugs considered safe in pregnancy at the era of big data: the everlasting case of doxylamine.
Journal: Journal of clinical epidemiology
Published: July 12, 2022
Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy.
Journal: Nature reviews. Endocrinology
Published: December 15, 2021
Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).
Journal: Basic & clinical pharmacology & toxicology
Published: September 22, 2020
Last Updated: 09/26/2026